Precede Biosciences logo

Associate Director/Director, Translational and Clinical Science Operations Lead

Precede Biosciences

Cambridge, MAHybridPosted 2 days ago$180,000 - $240,000 per year
Full TimeDirector & AboveClinical DevelopmentDiagnostics
Original posting ↗

Summary

Precede Biosciences is seeking a Translational and Clinical Science Operations Lead to own clinical study plans, specimen sourcing, cohort assembly, and outsourced biomarker testing across translational research and clinical assay development programs. Partnering with Laboratory Operations, Clinical Data Management, and Translational and Development teams, you will translate study requirements into operational workflows and deliver the specimens, complementary testing, and associated data needed for analysis. You will work closely with a dedicated Project Manager to establish feasible milestones, resource requirements, and budgets.

Job description

The Opportunity

Precede Biosciences is seeking a Translational and Clinical Science Operations Lead to own clinical study plans, specimen sourcing, cohort assembly, and outsourced biomarker testing across translational research and clinical assay development programs. Partnering with Laboratory Operations, Clinical Data Management, and Translational and Development teams, you will translate study requirements into operational workflows and deliver the specimens, complementary testing, and associated data needed for analysis. You will work closely with a dedicated Project Manager to establish feasible milestones, resource requirements, and budgets.

What You'll Do

  • Translate study requirements into acquisition plans. Define operational requirements for cohort composition, clinical annotations, collection timepoints, comparator measurements, and specimen quantities with translational and development leads.
  • Own specimen sourcing and cohort assembly. Evaluate commercial providers, biobanks, repositories, and prospective collection options against quality, availability, permitted-use, cost, and timeline requirements. Track acquisition gaps, participant overlap, and readiness across discovery, development, validation, and bridging cohorts.
  • Coordinate specimen allocation and logistics. Partner with Laboratory Operations on acceptance criteria, accessioning, aliquoting, sectioning, shipping, storage, and reserves across internal and external assays.
  • Ensure specimen and clinical data readiness. Work with Clinical Data Management to reconcile identifiers, provenance, collection details, and required annotations. Resolve discrepancies before testing and analytical handoff.
  • Manage external biomarker testing. Coordinate provider qualification, pilot studies, and testing for tissue RNA sequencing, IHC, spatial profiling, DNA sequencing, proteomics, and other measurements. Define technical scopes and acceptance criteria with scientific and Quality colleagues.
  • Oversee vendor execution and data delivery. Track sample transfers, testing progress, QC, repeat testing, and corrective actions. Establish required file formats, raw and processed outputs, assay metadata, and QC documentation with data teams.
  • Support Clinical Trial Assay (CTA), LDT, and Companion Diagnostic (CDx) development by managing specimen reserves, building comparator datasets, supporting reproducibility studies, and assay bridging requirements.
  • Improve operational processes. Establish specimen and testing SOPs, trackers, and handoff criteria. Monitor acquisition yield, rejection rates, sample metadata completeness, turnaround, and costs, and provide operational forecasts and risks to the Project Manager.

Who You Are

  • Bachelor's or master's degree in life sciences, clinical research, or a related discipline, or equivalent relevant experience.
  • Minimum of 8 years of experience in translational operations, biomarker operations, clinical research, or molecular diagnostics.
  • Hands-on experience sourcing human biospecimens and assembling clinically annotated oncology cohorts.
  • Experience selecting and managing external laboratories, biospecimen providers, and outsourced testing.
  • Understanding of preanalytical variables, specimen allocation, assay QC, and molecular and clinical data requirements.
  • Strong operational judgment, attention to detail, and ability to resolve issues across scientific, laboratory, and data teams.

Additional Valuable Experience

Liquid biopsy or epigenomics; matched plasma and tissue sourcing; longitudinal or rare tumor cohorts; integrated molecular profiling; clinical assay validation; or LIMS and specimen inventory systems.

Requirements

  • Bachelor's or master's degree in life sciences, clinical research, or a related discipline, or equivalent relevant experience
  • Minimum of 8 years of experience in translational operations, biomarker operations, clinical research, or molecular diagnostics
  • Hands-on experience sourcing human biospecimens and assembling clinically annotated oncology cohorts
  • Experience selecting and managing external laboratories, biospecimen providers, and outsourced testing
  • Understanding of preanalytical variables, specimen allocation, assay QC, and molecular and clinical data requirements
  • Strong operational judgment, attention to detail, and ability to resolve issues across scientific, laboratory, and data teams

Benefits

  • Performance Bonuses
  • Equity Participation
  • Comprehensive Health Benefits

Company overview

Precede Biosciences is a pioneering biotechnology company that has developed a first-in-class liquid biopsy platform to revolutionize precision medicine. Founded in 2021 and headquartered in Boston, Massachusetts, the company emerged from stealth in 2023 with $57 million in Series A funding from prominent investors including 5AM Ventures and Lilly Asia Ventures. Precede's breakthrough technology enables comprehensive epigenomic profiling from just 1mL of plasma, simultaneously analyzing circulating chromatin and the DNA methylome to reveal disease-defining transcriptional biology. This unique platform provides unprecedented resolution into the dynamic activity of individual genes and pathways in diseased tissues, offering capabilities beyond conventional genomic liquid biopsy technologies that focus primarily on somatic mutations. The company's approach is particularly valuable for drug development partnerships, enabling the identification of biology associated with treatment response and resistance, as well as novel therapeutic targets. Precede is actively developing blood-based clinical tests to advance precision use of cancer medicines in clinical practice, addressing the limitations of invasive tissue-based diagnostics. With applications spanning oncology, auto-immunity, and other conditions, Precede Biosciences aims to improve drug development success rates and build a future where every patient can receive minimally invasive, biology-informed diagnosis and therapy.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.